Navigation Links
A1-Antitrypsin

ProductsA1-Antitrypsin
Company ARUP Laboratories
Item A1-Antitrypsin
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. A Vitamin, Serum
2. B1 Vitamin, Plasma
3. B1 Vitamin, Urine
4. B1 Vitamin, Whole Blood
5. B6 Vitamin, Plasma
6. B2 Vitamin, Plasma
7. C, Vitamin, Plasma
8. E, Vitamin, Plasma or Serum
9. K1, Vitamin, Serum
10. Plasmacup SC
11. Rapid Plasma Reagin (RPR) Sset
Slides contain two wells: a positive control containing Nocardia asteroides ATCC ® 3308 in simulated sputum and a negative control containing Streptomyces albus subsp. albus ATCC ® 3004 in si
...With 384 Well Plate Capability The Equalizer 384...iginal Equalizerexpandable and equal tip spacing, ...onents, and in-lab calibration capabilities. In ad... tips down to 4.5mm for loading and accessing many...
... Tip System A lower cost alternative to Equalizer...ulti-sample transfers between two different vessel...tip spacing can be quickly and easily adjusted for... plates. Ergonomic Design for Unparalleled Comfor...
... Tip System A lower cost alternative to Equalizer...ulti-sample transfers between two different vessel...tip spacing can be quickly and easily adjusted for... plates. Ergonomic Design for Unparalleled Comfor...
Medicine Products:
(Date:9/4/2008)... Experts develop sequence of instructions they say...HURSDAY, Sept. 4 (HealthDay News) -- Vaccine safet...c to vaccines can receive vaccinations with close ..., Reporting in the September issue of Pediatrics ...ren,s Center put forth a step-by-step set of instr...
(Date:9/4/2008)..., Medelis, an oncology co... abstract, "Preclinical Trials: A Nuanced App... abstract, Dr. Mike McGarry, a preclinical researc... how oncology preclinical studies are commonly vie...ely by researchers who operate without true integr...
(Date:9/4/2008)... *Special display of Palestinian and Israeli t... 4 /PRNewswire-USNewswire/ -- America must take a ...ions to violence in the world,says Ira Magaziner,... board,and former Senior White House Advisor for P...ho will be the keynote speaker at a conference at,...
(Date:9/4/2008)... - New Educational Program Kicks Off September,s... Month -, LOS ANGELES, Sept. 4 /PRNewswire/...OCC) launched its newest educational initiative, E...oulevard 3 to honor survivors,friends and family ...cate,women nationwide about the symptoms and risk ...
Breaking Medicine News(10 mins):Health News:Even Kids With Known Allergies Can Be Safely Vaccinated 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 2Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 3Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 4Health News:National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Eva's Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer 2Health News:National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Eva's Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer 3
...Care has come out with results from its survey of ...nt schools in UK were quizzed. It was seen that ...up daily. The research also claimed that surprisin... in smoking. Government’s targets are aimed at red...
...of India (OPPI) has demanded that the federal gove...ied on certain life-saving drugs. In the budget...st, Finance Minister P.Chidambaram had proposed a ...ugs. The older ones were not touched, though. &#...
...inistry of health in New Zealand, school children ...erm.// These guidelines on food will be launched i...e across the country. Pamela Peris feels the imp...lue of pie as against the fresh sandwich. She also...
... have to go through ‘one of the most stressful thi...was suffering from an acoustic neuroma - a form of...d connected to monitors, before the 18-hour-long b... was then that doctors noticed three sets of non-s...
Other Medicine News:
(Date:9/4/2008)... MELBOURNE, Australia, Sept. 4 /- C...is commencing enrolment for its Phase Ib/II,study ... anticancer agent,in patients with an aggressive ...rme (GBM)., The GBM clinical trial is the first P...umor indications for the company and the second in...
(Date:9/4/2008)...Another Roche first in TaqMan(R) real-time PCR tes... lab, PLEASANTON, Calif., Sept. 4 /PRNewswi...as approved the Roche COBAS(R) TaqMan(R) HBV Test,...s DNA approved in the U.S.,The test uses Roche,s r...Hepatitis B virus DNA in a patient,s blood. Doctor...
(Date:9/4/2008)... BIRMINGHAM, Ala., Sept. 4 /- South...tional Institutes of Health (NIH) has selected,the...olecular Libraries,Probe Production Center Network...twork -- is part of the Molecular Libraries Progra...en scientific knowledge of the human,genome and va...
(Date:9/4/2008)... Updated Survival Data for Ipilimumab to...re-FirstCall/ -- Medarex, Inc.,(Nasdaq: MEDX ) an...limumab,an investigational anti-CTLA-4 antibody, ...sentations at the 33rd Congress of the European So...mber 12-16, 2008 in Stockholm.,Many of the followi...
Breaking Medicine Technology:Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Research warns that human papillomavirus might cause bladder cancer 1976 1Research warns that human papillomavirus might cause bladder cancer 1976 2US hospitals report infections increasing in frequency and cost 1974 1US hospitals report infections increasing in frequency and cost 1974 2UC Riverside biologist receives prestigious MacArthur Fellowship 554 1UC Riverside biologist receives prestigious MacArthur Fellowship 554 2UC Riverside biologist receives prestigious MacArthur Fellowship 554 3Researchers set new record for brightness of quantum dots 552 1Researchers set new record for brightness of quantum dots 552 2
... Proportionality of,Company,s Once-Daily Tramadol ...AL, QC, June 29, 2007 /PRNewswire-FirstCall/ - Lab... poster discussing the dose,titration of its once-...onal Forum on Pain Medicine to be held June 28 to ...pares two different titration schedules for,Laboph...
...BioPharma, Inc.,(OTCBB: DORB) ("DOR" or the "Compa...esting of a multivalent form of its botulinum,toxi...the journal,Infection and Immunity (Ravichandran e...3 ). These results are the first that,describe the...cine,that is active by the mucosal route. The vacc...
Other Medicine Technology:Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 2Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 6